Capital Fund Management S.A. Royalty Pharma PLC Put Options Transaction History

Capital Fund Management S.A.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	SELL	$25.63 - $29.27 $302,434 - $345,386	-11,800 Reduced 51.08%	11,300 $319,000
Q2 2024 Aug 13, 2024	SELL	$26.26 - $29.9 $601,354 - $684,710	-22,900 Reduced 49.78%	23,100 $609,000
Q1 2024 May 15, 2024	SELL	$27.46 - $31.33 $790,848 - $902,304	-28,800 Reduced 38.5%	46,000 $1.4 Million
Q4 2023 Feb 14, 2024	BUY	$26.21 - $29.22 $516,337 - $575,634	19,700 Added 35.75%	74,800 $2.1 Million
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $1.45 Million - $1.73 Million	55,100 New	55,100 $1.5 Million

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.